Embolization may be the primary and exclusive treatment of cerebral arteriovenous malformations. To evaluate its benefits, a group of 27 patients was studied f o r the incidence of hemorrhages, headaches, seizures, and neurologic deficits, both before and after Silastic sphere embolization . Questionnaires to patients and phYSicians were used. Embolization was found to decrease the frequency of headaches in most patients with this symptom , but had no effect on the frequency of seizures when patients in whom medical therapy was altered were excluded nor on the progression or incidence of neurologic signs and symptoms. The effect of embolization on the incidence of recurrent hemorrhages is as yet undetermined .
Cerebral arteriovenous malformations are vascular hamartomas with arteriovenous shunts [1] . They occ ur more often in the brain than elsewhere in the body [2] and are the most common of all the vascul ar malformations of the central nervous system. Their incidence in the United States population has been estimated at 0.14 % (280 ,000 people) [3] . They accounted for about 0 .6% of the patients with nontraumatic subarachnoid hemorrhage in one study [4] . In addition to hemorrhage , which has been reported as the main complaint in 30 % -76 % of the patients [5, 6] , many patients had head aches or seizures.
Most cerebral arteriovenous malformations probably enlarge progress ively, although cases of regression or spontaneous disappearan ce have been reported [7] . Because of the potential devastating effects of an intracerebral hemorrhage, therapy is usually directed to surg ical removal or embolization of the lesions. Embolization has been advocated also as an aid to surgery. While it is known that surgical removal of the lesions complete ly removes the risk of recurrent hemorrhages, the effects of embolization alone on the natural history of the lesions and their accompanying symptoms is largely unknown . We report a follow-up study of the incidence of hemorrhages, headaches, se izures , and neurologic deficits in a selected group of patients with ce rebral arteriovenou s malformations treated exclusive ly with caro tid and vertebral embo li zation. Th e information was obtained from th e pati ents and from their attend ing physicians.
Subjects and Methods

Patient Population
During a 7 year peri od, 63 patients wit h cerebral arteriovenous malforma ti ons we re embolized . In 32 pati ents, surgery was co nsidered feasibl e, but the malform ations were located in parts of th e brain where surg ical control of th e feeding arteries was th ought to be diffic ult or the malform ation s were considered too large for successful removal without significant morbidity , thu s necessitating presurgical emboli zation. All 32 patients subsequently underwent surgery.
In a second group of 3 1 pati en ts, the malformations we re co nsidered too large to be successfully removed surgicall y or they were situated in c ritical areas of the brain where surgery was not considered possible. Embolization alone was carri ed out in thi s g roup to attempt to reduce th e size of the malformati ons and th eir feeding arteri es and draining veins. Correction of the altered hemodynamics of th e cerebral circul ation was also considered desirabl e. In both groups, the benefits of redu c ing th e size of th e feeding arteries or of th e arteriovenous malformation itself were considered to outweigh th e ri sk of embolization.
Follow-up
In th e second group of 3 1 pati ents, th e follow-up information was obtain ed from q uesti onnaires mailed to th e patients and th eir physicians. Responses were received from 23 (74%) of the 3 1 patients and from 11 (36%) of th eir ph ys ic ians. The follow-up patient group was composed of th e 27 pati ents wh o either responded th emselves or wh ose phys icians responded or both. Five of the physic ian responses regard ed pati ents who did not respond th emselves. In four cases, we received no response either from the pati ents or their ph ys icians; in two of th ese pati ents, becau se of th e larg e size of th e shunts within th e malform ati on, embolizati on was known to have been in adeq uate.
Th e pati ent q uesti onnaire inquired about recurrence of hemorrh age, severity and intensity of headache, seizure activity, and neurolog ic c hanges. If mo re th an one embolization procedure was carri ed out , pati ents we re asked about th eir response to each procedure. Th e physic ian questi onnaire requested th e ph ys ic ian' s evalu ati on of th e pati ent 's statu s and of the contributio n th at th e emboli zati on( s) had made to each patient 's care .
Technique
Embolizati on was carri ed out vi a the percutaneous transfemoral approach using th e Seldinger technique. Catheters were placed in th e appro pri ate carotid or vertebral artery . Prior to embolization, 10 mg of Decadron were administered intravenously. Barium-impregnated Silasti c emobli were injected, and their location in the brain was determin ed by frontal and lateral skull films . In 26 patients, 2 mm or smaller emboli were injected ; in one patient, both 2 and 3 mm emboli we re injected. Th e procedure was terminated after 60 emboli were injec ted , wh en emboli were seen to stray into normal arteri es, or wh en neurologic complications occurred [8] .
Both pre-and postembolization angiograms were obtained in all pati ents. Th e postemboli zation angiograms were studied to determine th e hemodynami c benefits of embo lization . Partial obliteration of th e arteriovenous malform ati on (in no pati ent was the malformation completely obliterated), slowing of th e circ ulation time through th e malform atio n, stasis of contrast materi al within the feeding arteri es to or draining vein s from th e malfo rm ation , and oc clusion or decreased size of th e feeding arteries to th e malformation were all considered benefic ial. A return to a normal c irc ulation with eliminati on or decrease of an arteri al steal was also con sidered desirabl e.
In each of 18 pati ents, 20 or more emboli were injected into th e cerebral arteri es. Benefi c ial results were obtained in all 18. In 13 pati ents, fewer th an 20 emboli were injected ; nine received 10-20 and four received fewer th an 10. In th e gro up of nine patients, examinatio n of th e postembolization angiograms demonstrated no c hange in th e hemodynamics of th e arteri ovenous malformation in eight pati ents; in one pati ent , th ere was partial obliteration of the malform ati on. In th e g roup of fo ur pati ents, embo lization had no effect .
Results
Of th e 27 pati ents on whom data are available , 18 were men and nine were women. Thei r mean age was 35.3 years at the time of embolization (men, 37 .2 ; women, 31.4). The mean follow-up time was 2 .25 years ± 1.74 months (SO) (range , 3 months to 6 years).
Cerebral hemorrhages did not rec ur in four of the five patients who had had hemorrhages before embolization . In one patient who had hemorrhag es at ages 7, 15, 18, and 20 years , embolization was carried out at age 21 with a good result as determined angiographically. In the ensuing 5 years , she had no further hemorrhages. In another patient, embolization was carried out at age 23 years after a single hemorrhage. It was considered beneficial angiographically, and there were no rec urrences in the ensuing 23 months. In the third patient, there had been two hemorrhages at ages 42 and 44 years . Three embolization procedures were carried out with beneficial angiographic results . There were no recurrent hemorrhages in the ensuing 3 years . One patient had a single hemorrhage about 1 month before embolization at age 24 years . Embolization was considered of no angiographic benefit , and there was no recurrence in the 10 months of follow-up. In only one patient did a hemorrhage recur after embolization . The patient had four hemorrhages in 11 years, from ages 29 until 40 years . Embolization was carri ed out without any beneficial result as determined angiographically. Si x months later, the patient had a further hemorrhag e. In the next year, there were no further hemorrhages , but there was one episode of weakness of the arm and leg .
Nineteen of the 27 patients were originally seen because of headaches. After embolization , 12 patients reported that their headac hes had disappeared or decreased in intensity. In 11 of the 12, embolization was beneficial angiographic ally . It was also beneficial angiog raphically in the seven patients whose headaches did not change . In one patient, an in itial lessening of the headac hes was followed by a worsening ; in one patient, the headaches became shorter but sharper; and in five patients, embolization had no effect on the frequency or intensity of the headaches. In no patients were the headaches worse in the initial period after embolization .
Eighteen of the 27 patients were seen initially because of seizures. After embolization, the seizures decreased in frequ ency or disappeared in 11 patients. However, in seven of the 11 patients, the anti convulsant therapy after embolization was either different or increased in quantity; in the other four, it was the same , less, or discontinued. In eight of the 11 patients, angiography showed the embolization to be beneficial. In five of the 18 patients, embolization had no effect on the seizures, and , in two of the 18, the seizures were more frequent even though the quantity of medication was increased . In these latter patients in whom the seizures were unchanged or worse , embolization appeared beneficial angiographically in all seven .
In three of five patients who had transient ischemic attacks, the attacks ceased after embolization . In two of these three, embolization was benefici al angiographically. In two patients with transi ent ischemic attacks, the attacks were as frequent after embolization as before. In one of these two patients, embolization was considered of no benefit angiographi cally.
Neurologi c deficits were present before embolization in five patients. The quadrantanopsia in one patient disappeared, and, in one patient, weakness and clumsiness of the hand improved after embolization; in both patients, embolization was of benefit as determined angiographicall y. In two patients, one with paresis of the hand and one with hemiparesis of the hand and leg, the weaknesses progressed over the ensuing months, even though in both the embolization appeared to be beneficial angiographically; one of these patients also had a hemorrhage after embolization. In one patient, there was a progressive deterioration in memory and a change in personality, even though the arteriovenous malformation decreased in size after embolization. Emboli strayed in 20 patients. There were temporary compl ications, none longer than 2 days, in six of these 20 patients . Permanent complications occurred in two patients. In one patient with a left hemiparesis, even though embolization was beneficial, the hemiparesis became worse , and a hemianopsia also developed that persisted for 6 months. The second patient had four previous hemorrhages, and, at the time of embolization, a right hemiparesis and right inferior quadrantanopsia were present. Three separate embolization procedures were carried out, all with angiographic benefit. However, immediately after the last procedure, a right homonymous hemianopsia developed that was still present 5 years later.
Discussion
Patients with cerebral arteriovenous malformations are at considerable risk of morbidity or death. The natural history of the untreated disease indicates that 10%-17% will die from hemorrhages and 40% -50% will have their working capacity reduced or will become invalids over the next 20-40 years [4, 9] . In one study of 55 patients, surgical excision of the malformation was carried out with less than 10% morbidity and a 2% mortality. In 44 of the 55 patients (69 procedures), embolization , using particu late barium-impregnated Silastic spheres, was performed with a less than 2% permanent morbidity and no deaths [10] .
Cerebral arteriovenous malformations can also be treated by using flow-directed balloon catheters for controlled injection of tissue adhesives. While the latter technique has had notable successes, to our knowledge, a statistical analysis of the results of the technique has not been published, and there have been reports describing the risks of balloon catheterization in patients with cerebral arteriovenous malformations. With the development of safer, less traumatic balloons, the injection of tissue adhesives into the nidus of the malformation may become the procedure of cho ice.
In our series , five patients had hemorrhages before embolization. In four, the hemorrhages did not recur. The natural history of ruptured arteriovenous malformations indicates that if a patient has had a hemorrhage, there is a one-in-four chance of recurrent bleeding within 4 years [9] . Luessenhop and Presper [11] considered it unlikely that embolization protected a patient from cerebral hemorrhages. The average follow-up in their series was 4 years; in our series, it has been 5 , 2, 3 , 1, and 1 years (average , 2.4 years). Longer fol low-ups of more patients are needed to establish whether or not embolization protects a patient from hemorrhages.
Embolization appeared to be of considerable benefit in reducing or eliminating the headache in 12 of 19 patients. However, in the seven patients in whom embolization had no effect on the severity of the headaches, embolization was considered beneficial angiographically. Similarly, Luessen hop and Presper [11] found embolization very effective in headache control.
While our data indicate that embolization reduced the incidence of seizures in 11 of 18 patients, in only four patients was the quantity of anticonvulsant medication the same or less after embolization . In three of the four patients , embolization achieved some benefit as determined angiographically (decrease in size of arteriovenous malformation in one, perfusion of normal brain in one, and both decrease in malformation size and perfusion of normal brain in one). These data should be compared with those of five of the 18 patients in whom the seizure incidence was unchanged and with two of the 18 patients in whom, even though the malformation was decreased in size after embolization, the seizure frequency increased . Therefore, our data do not confirm the opinion of Kusske and Kelly [1 2], who described a major decrease in the frequency and severity of seizures after particulate embolization in si x of eight patients. We concur with Luessenhop and Presper [11] that embolization alone does not reduce the incidence of seizures.
The effect of embolization on neurologic deficits seemed varied . Transient ischemic neurologic attacks disappeared in three patients but persisted in two . Similarly, there was a considerable improvement in neurologic deficits in two pati ents, but progression of the deficits in two others , and progressive mental deterioration in one. In two patients, embolization caused complications. In the Luessenhop and Presper [11] series, embolization arrested progression of the neurologic deficits in eight of 12 patients.
Many patients had a feeling of increased vigor and wellbeing after embolization . The significance of that is difficult to determine. It either represents a physio logic response or a manifestation of the relief and gratitude felt by the patients after therapy for a potentially catastrophic disease.
To conclude, our data indicate that , in patients with large, surgically inaccessible cerebral arteriovenous malformations , embolization reduces the frequ ency of headaches but has no beneficial effect on the frequency of seizures or on the development of neurologic deficits. As yet, the effect of embolization on the in cidence of recurrent hemorrhages is undetermined . 
